Adaptive Biotechnologies Corporation
ADPT
$9.29
-$0.22-2.31%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 10.50% | 2.21% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 10.50% | 2.21% | |||
| Cost of Revenue | 138.04% | -209.32% | |||
| Gross Profit | -61.49% | 1,543.07% | |||
| SG&A Expenses | 2.06% | 4.82% | |||
| Depreciation & Amortization | -2.10% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.92% | 2.82% | |||
| Operating Income | 12.51% | -3.69% | |||
| Income Before Tax | 11.53% | -5.05% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 11.53% | -5.05% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -188.00% | -3.85% | |||
| Net Income | 11.40% | -5.05% | |||
| EBIT | 12.51% | -3.69% | |||
| EBITDA | 15.37% | -4.81% | |||
| EPS Basic | 12.28% | -4.92% | |||
| Normalized Basic EPS | 13.18% | -9.50% | |||
| EPS Diluted | 12.28% | -4.92% | |||
| Normalized Diluted EPS | 13.18% | -9.50% | |||
| Average Basic Shares Outstanding | 1.03% | 0.11% | |||
| Average Diluted Shares Outstanding | 1.03% | 0.11% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||